FDA advisory meeting on J&J emergency approval request set for Feb. 26

(Please visit the site to view this media)

Johnson & Johnson applied for an emergency use authorization from the Food and Drug Administration for its coronavirus vaccine after releasing data last week showing it was about 66% effective in protecting against the virus. CNBC's Meg Tirrell reports.

…(read more)

Forward this article via email:  Send a copy of this story to someone you know that may want to read it.


FDA advisory meeting on J&J emergency approval request set for Feb. 26
FDA advisory meeting on J&J emergency approval request set for Feb. 26

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *